CA Patent

CA2107196A1 — Carboxamide derivatives

Assigned to Mitsubishi Chemical Corp · Expires 1994-03-30 · 32y expired

What this patent protects

ABSTRACT OF THE DISCLOSURE Carboxamide derivatives of the following general formula (I): (I) (wherein R1 and R2 are C1-C3 alkyl group or both taken together C1-C3 alkylene group, R3 is hydrogen atom, dialkylamino group, etc., R4 is hy…

USPTO Abstract

ABSTRACT OF THE DISCLOSURE Carboxamide derivatives of the following general formula (I): (I) (wherein R1 and R2 are C1-C3 alkyl group or both taken together C1-C3 alkylene group, R3 is hydrogen atom, dialkylamino group, etc., R4 is hydrogen atom, C1-C10 alkyl group, R5 is C1-C10 alkyl group, m, n, q are an integer from 0 - 3, p is 0, 1, A ring is , , B ring is 5 or 6 membered nitrogen containing aromatic ring, are provided, which are useful as medicinals for treating hyperlipemia or atherosclerosis.

Drugs covered by this patent

Patent Metadata

Patent number
CA2107196A1
Jurisdiction
CA
Classification
—
Expires
1994-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Mitsubishi Chemical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.